For patients who may not have achieved optimal results with dual agonists, or those with unique comorbidities like advanced non-alcoholic fatty liver disease (NAFLD), the introduction of Retatrutide is not just an incremental improvement, it is a re-evaluation of treatment goals
Other drugs used in the treatment of TTM are lamotrigine, olanzapine, N-Acetylcysteine, inositol, and naltrexone
combined mechanisms and outcomes in humans are not established
Understanding that this fatigue results primarily from reduced calorie intake and rapid metabolic changes rather than direct medication toxicity helps you address it effectively through proper nutrition, hydration, and lifestyle strategies
2 Most oncologists prefer people to have finished active treatment (surgery, chemotherapy, radiotherapy) and to be in documented complete remission before starting Wegovy